Author

Christian Lodberg Hvas 1

1 Aarhus University Hospital,Aarhus,Denmark

ADALIMUMAB AND INFLIXIMAB CLEARANCE IN NEONATES (ERA STUDY)

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter R. Gibson, Richard Blair Gearry, Jan Fallingborg, jens kjeldsen, Signe Wildt, Lise Svenningsen, William Connell, Christian Lodberg Hvas, Miles P. Sparrow, Alissa Walsh, Susan J. Connor, Graham Radford-Smith, Ian Lawrance, Jane Andrews, Katie Ellard, Ourania Rosella, Ann

Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn's disease

Joachim Høg Mortensen, Morten Asser Karsdal, Henning Grønbæk, Christian Lodberg Hvas, Anders Dige, Tina Manon-Jensen

EFFECTS OF ANTI-TNF-Α AND STEROID TREATMENT ON MACROPHAGE ACTIVATION ESTIMATED BY SOLUBLE CD163 LEVELS IN INFLAMMATORY BOWEL DISEASE

Anders Kirch Dige, Sidsel Stoy, Karen Louise Thomsen, Christian Lodberg Hvas, Jørgen Agnholt, Holger Jon Moeller, Henning Grønbæk, Anders Dige, Christian Lodberg Hvas

HIGH DOSE ORAL THIAMINE REDUCES CHRONIC FATIGUE IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE: A RANDOMISED DOUBLE BLINDED CROSSOVER TRIAL

Palle Bager, Christian Lodberg Hvas, Charlotte Rud, Jens Frederik Dahlerup

HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN’S DISEASE

Joachim Høg Mortensen, Morten Asser Karsdal, Christian Lodberg Hvas, Anders Kirch Dige, Henning Grønbæk, Anne-Christine Bay-Jensen

IS FECAL CALPROTECTIN THE BETTER TOOL TO MONITOR DISEASE ACTIVITY IN PREGNANT IBD PATIENTS?

Mette Julsgaard, Lisbet Ambrosius Christensen, Christian Lodberg Hvas, Jan Fallingborg, Lise Svenningsen, jens kjeldsen, Miles P. Sparrow, Signe Wildt, Sally J. Bell

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

Kent Haderslev, Marianne Kajbæk Vester-Andersen, Asser Mathiassen Oppfeldt, Anja Poulsen, Akbar Molazahi, Malte Rosager Hansen, Anders Bergh Lødrup, Natalia Pedersen, August Pilegaard Prahm, Lone Larsen, Henning Glerup, Mohamed Attauabi, Tine Jess, Abdel Wase, Torben Nathan, Anders Neumann, Jakob Benedict Seidelin, Christi

OUTCOMES OF FIRST-LINE BIOLOGICALS IN A MULTICENTER PROSPECTIVE COHORT OF BIOLOGICAL-NAÏVE IBD PATIENTS – THE DANISH IBD BIOBANK PROJECT

Mirabella Zhao, Andreas Munk-Petersen, Dorte Christiansen, Anja Poulsen, Lone Larsen, Anders Kirch Dige, Christian Lodberg Hvas, Johan Burisch, Jakob Benedict Seidelin, Flemming Bendtsen, Mads Wewer, Bobby Lo, Mohamed Attauabi

RANDOMISED CLINICAL TRIAL: CASEIN GLYCOMACROPEPTIDE FOR ACTIVE DISTAL ULCERATIVE COLITIS – A PILOT STUDY

Pernille Glahn Wernlund, Christian Lodberg Hvas, Anders Kirch Dige, Mia Bendix, Lisbet Ambrosius Christensen, Jens Frederik Dahlerup, Jørgen Agnholt

RANDOMIZED CONTROLLED CLINICAL TRIAL: FAECAL MICROBIOTA TRANSPLANTATION (FMT) IS SUPERIOR TO BOTH FIDAXOMICIN AND VANCOMYCIN MONOTHERAPIES FOR RECURRENT CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE

Christian Lodberg Hvas, Simon Mark Dahl Jørgensen, Søren Peter Jørgensen, Merete Storgaard, Lars Lemming, Christian Erikstrup, Jens Frederik Dahlerup

Item 1 - 10 / 19
1
2